Dr Anne Horne

Selected publications and creative works (Research Outputs)

  • Reid, I. R., Horne, A. M., Mihov, B., Stewart, A., Garratt, E., Bastin, S., & Gamble, G. D. (2019). Effects of Zoledronate on Cancer, Cardiac Events, and Mortality in Osteopenic Older Women. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research10.1002/jbmr.3860
    Other University of Auckland co-authors: Ian Reid, Greg Gamble
  • Dalbeth, N., Billington, K., Doyle, A., Frampton, C., Tan, P., Aati, O., ... Stamp, L. K. (2019). Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual-Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial. Arthritis & rheumatology (Hoboken, N.J.), 71 (10), 1739-1746. 10.1002/art.40929
    URL: http://hdl.handle.net/2292/48348
    Other University of Auckland co-authors: Anthony Doyle, Nicola Dalbeth
  • Bolland, M. J., Horne, A. M., Briggs, S. E., Thomas, M. G., Reid, I. R., Gamble, G. D., & Grey, A. (2019). Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy. Calcified tissue international, 105 (4), 423-429. 10.1007/s00223-019-00579-0
    Other University of Auckland co-authors: Mark Bolland, Mark Thomas, Ian Reid, Greg Gamble, Andrew Grey
  • Cronin, O., Forsyth, L., Goodman, K., Lewis, S. C., Keerie, C., Walker, A., ... Selby, P. L. (2019). Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone. BMJ open, 9 (9)10.1136/bmjopen-2019-030689
  • Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Merriman, T. R., ... Dalbeth, N. (2019). Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration. Clinical and translational science10.1111/cts.12686
    Other University of Auckland co-authors: Nicola Dalbeth
  • Bristow, S. M., Horne, A. M., Gamble, G. D., Mihov, B., Stewart, A., & Reid, I. R. (2019). Dietary Calcium Intake and Bone Loss Over 6 Years in Osteopenic Postmenopausal Women. The Journal of clinical endocrinology and metabolism, 104 (8), 3576-3584. 10.1210/jc.2019-00111
    Other University of Auckland co-authors: Bobby Mihov, Greg Gamble, Ian Reid
  • Reid, I. R., Horne, A. M., Mihov, B., Stewart, A., Garratt, E., Wiessing, K. R., ... Gamble, G. D. (2019). Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trial. Journal of internal medicine, 286 (2), 221-229. 10.1111/joim.12901
    URL: http://hdl.handle.net/2292/46781
    Other University of Auckland co-authors: Ian Reid, Bobby Mihov, Mark Bolland, Greg Gamble
  • Horne, A. M., Mihov, B., & Reid, I. R. (2019). Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up. Calcified tissue international, 105 (1), 107-108. 10.1007/s00223-019-00553-w
    Other University of Auckland co-authors: Ian Reid, Bobby Mihov

Identifiers

Contact details

Primary office location

M&HS BUILDING 502 - Bldg 502
85 PARK RD
NZL
AUCKLAND 1023
New Zealand

Web links